Open

Coming up

Don't miss

Replay


LATEST SHOWS

IN THE PAPERS

Is Valls crying wolf?

Read more

IN THE PAPERS

Prospect of separation from Scotland stirs sadness in England and Wales

Read more

BUSINESS DAILY

No resolution in sight to Air France dispute

Read more

MEDIAWATCH

Fighting back against facial recognition

Read more

THE INTERVIEW

Iraqi Foreign Minister Ibrahim al-Jaafari

Read more

AFRICA NEWS

Central African Republic: UN takes over country's peacekeeping

Read more

WEB NEWS

News media urged not to show ISIS videos

Read more

DEBATE

Fighting the Islamic State group: What coalition against jihadists? (part 2)

Read more

DEBATE

Fighting the Islamic State group: What coalition against jihadists?

Read more

Britain to map 100,000 DNA code sequences

AFP

British scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister saysBritish scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister says

British scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister saysBritish scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister says

British scientists are to map 100,000 complete DNA code sequences in a project that will make the country a world leader in genetic research on cancer and rare diseases, the prime minister said on Friday.

David Cameron announced £300 million ($507 million, 378 million euros) in deals to fund the mapping project, predicted to be complete by 2017.

The project will sequence the genetic codes of about 75,000 patients with cancer and rare diseases, and those of their close relatives.

Both the healthy and the tumour cells of the cancer patients will be mapped, meaning about 100,000 will be sequenced in total.

"This agreement will see the UK lead the world in genetic research within years," Cameron said.

"As our plan becomes a reality, I believe we will be able to transform how devastating diseases are diagnosed and treated in the NHS and across the world."

Scientists hope that identifying tiny changes in the genetic code that can trigger disease will allow for personalised and more effective treatments.

An example of this kind of therapy is Herceptin, a drug which treats a breast cancer variant characterised by over-activity of the Her2 gene.

DNA samples have already been donated by a few hundred participants in a pilot, and about 10,000 are expected to have donated by the end of the year.

Among the cancers due to be targeted are bowel, breast, leukaemia, lung, ovarian, prostate and leukaemia.

Charity the Wellcome Trust, the Medical Research Council and Britain's National Health Service are contributing to the project, which will be overseen by Genomics England, set up by the Department of Health.

The Californian DNA sequencing company Illumina, which won a contract to provide the technology for the project, will also invest about £162 million in the project over its lifetime.

Wellcome Trust director Jeremy Farrar said genome sequencing could transform medicine.

"Twenty years from now academics and industry will have developed therapies which will be targeted at you and specific forms of cancer," Farrar said.

"We will look back in 20 years time and the blockbuster chemotherapy drugs that gave you all those nasty side effects will be a thing of the past."

Date created : 2014-08-01